Liberia

A worker at a UNICEF-supported Interim Care Center plays with 19-month-old Ebola survivor Tamba in Gueckedou, Forest Region, Guinea on January 11, 2015.  Tamba's mother died of Ebola, then his father abandoned him for fear of catching the disease himself.  UNICEF is working to break down the stigma around Ebola so children like Tamba still have homes to go to.

cnn.com - by Diana Magnay - January 30, 2015

Liberia (CNN) - First, the good news: Ebola is in decline.

2014 was a year of profound fear for communities living with -- and dying of -- the disease; of health workers making the ultimate sacrifice, dying as they tried to save; of apocalyptic forecasts as to the disease's possible spread. . .

. . . Ebola is still critically dangerous. Hotspots remain.

(READ COMPLETE ARTICLE)

INTERNATIONAL BUSINESS NEWS by Jayalaksmi K      Feb. 2, 2015

A common virus that infects billions at some point of their lives is believed to deliver some protection against other deadlier viruses like HIV and Ebola.

David O'Connor, a pathology professor at the University of Wisconsin in Madison, found the genetic fingerprints of the virus GBV-C in the records of 13 samples of blood plasma from Ebola patients.

While six of the 13 people who were co-infected with Ebola and GBV-C died, seven survived.

Combined with earlier studies that have hinted persistent infection with the virus slowed disease progression in some HIV patients, researchers think the virus could be beneficial.

"We're very cautious about over-interpreting these results," O'Connor told NPR. He is now waiting to get a bigger sample, to see if there really is a strong connection between GBV-C infection and survival.
Read complete story.

ASSOCIATED PRESS by JONATHAN PAYE-LAYLEH                                                        Feb. 2, 2015

MONROVIA--A large-scale human trial of two potential Ebola vaccines got under way in Liberia's capital Monday, part of a global effort to prevent a repeat of the epidemic that has now claimed nearly 9,000 lives in West Africa.

The trials in Liberia are taking place after smaller studies determined that the vaccines were safe for human use. By comparing them now with a placebo shot, scientists hope to learn whether they can prevent people from contracting the ghastly virus that has killed some 60 percent of those hospitalized with the disease.

Yet despite the trials' promise, authorities still must combat fear and suspicion that people could become infected by taking part. Each vaccine uses a different virus to carry non-infectious Ebola genetic material into the body and spark an immune response.

Read complete story.
http://abcnews.go.com/Health/wireStory/ebola-vaccine-trial-starts-liberia-28657084

              Parents resister pupils at Massaquoi less than a month after the last Ebola patient left the school.

WASHINGTON POST   by Martin Sieff                                                                             Feb. 1, 2015

MONROVIA--As the Ebola epidemic fades here, with fewer than 10 new cases reported per week, Liberia is beginning the massive challenge of resuming normal life. Many of its public institutions have been shuttered since June. Its economy has been paralyzed. More than 3,600 Liberians have died of the disease.

Those who endured the crisis are now grappling with a new set of predicaments: whether to sleep in the rooms where relatives died, to have babies in hospitals where Ebola patients were treated. In a country where containing Ebola meant persuading people to fear it, the public may remain traumatized for some time to come.